KPMG Global CEO Outlook – Life Sciences

Key findings
Hear from our leaders
Download the report

Our research finds that Life Sciences CEOs are confident in industry growth fueled by innovation, technological advancement, and operational efficiency. There is a strong appetite for mergers and acquisitions, substantial investments in AI and digitalisation, and a critical need to empower the workforce to navigate rapid change. While sustainability and ESG remain high on the agenda for Life Sciences organisations globally, there are shifting priorities across regions.

2025 Life Sciences CEO Outlook

Explore how leaders in the sector are navigating industry challenges and shaping their strategies for long-term success.

Download the report

Key findings

Organisations that have already adapted their growth strategies due to interrelated challenges

Life sciences: 80%
Cross sector average: 72%

86%

have a moderate-to-high appetite for M&A over the next three years

25%

integrate the costs and ROI of sustainability initiatives into every major capital investment

73%

expect most corporate staff to be working in hybrid models within three years

Hear from our leaders

Navigating the current landscape demands a proactive approach. We see a clear path forward by embracing innovation, making substantial investments in AI and digitalisation, and strategically pursuing mergers and acquisitions. Crucially, empowering our workforce to adapt to rapid change and integrating sustainability into our core strategies will be vital for sustained growth and success.

Irene Chu

Head of New Economy, Head of Life Sciences, ESG Reporting Lead

Hong Kong SAR, KPMG China

Why download the report?

By downloading the 2025 Life Sciences CEO Outlook, you’ll unlock unique perspectives on:

Industry growth prospects and drivers, M&A appetite, and operational challenges
AI and other capabilities investment
Workforce challenges and transformation
Evolution of ESG strategies

Enhance your strategic planning with expert analysis and actionable insights.

Download the report

Life Sciences

See how KPMG professionals help guide life sciences organizations, including medical device and biotechnology fields, to navigate complex business challenges.